GlycoEra secured CHF45M in Series A funding co-led by 5AM Ventures, Roche Venture Fund and Sofinnova Partners Biotech Health services Pharma Investments 04 November 2021 Share:
Round value (USD): 49.29m Round investors: Roche Venture Fund Sofinnova Partners 5AM Ventures LimmaTech Biologics AG Company: GlycoEra Industry: Biotech Health services Pharma
Nanolive raised $20 million series C backed by Taiwania Capital Biotech Competitive Intelligence Health services Pharma Software Services Investments 30 March 2022
Memo Therapeutics closed a Series B financing round of CHF37 million. Biotech Health services Manufacturing Investments 14 February 2022